PSA TOOL for Prostate Cancer Screening Discussions
Prostate Cancer
About this trial
This is an interventional supportive care trial for Prostate Cancer focused on measuring Screening, Shared Decision Making
Eligibility Criteria
Inclusion Criteria:
Provider:
- Provider at selected primary care practices in the Cleveland Clinic Health System
- Willing to utilize a guide to aid in decision making for prostate cancer screening
Patient:
- Patient of participating Cleveland Clinic primary care provider who is scheduled for a routine appointment with the provider
Exclusion Criteria:
- Not a patient or provider of the Cleveland Clinic Health System
Sites / Locations
- Cleveland Clinic, Case Comprehensive Cancer Center
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Provider Field Test
Patient test of revised PSA TOOL
15 providers will be given an initial version of the PSA TOOL, over a 4 week period, they will be able to provide feedback on the tool. This will be used to revise the screening decision aid. Informal interviews with providers will also be conducted by a member of the study team to obtain feedback about ease of use and usefulness of the tool.
150 patients will be asked to use the revised PSA TOOL. Pre- and Post-tests will be given to see if the tool changed the knowledge that patients have an option to be screened for prostate cancer and of specific factors to be considered in the screening decision. Informal interviews with patients who are exposed to the tool will also be conducted by a member of the study team to obtain feedback on issues addressed by the survey questions.